Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
- 2020 -
2021
-
2022
-
2023
-
2024
-
2025
August 2020 - 54 products
L
IP
Fulvestrant Accord 250
mg/5 ml
2
421.32
473.70
10 %
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Pemetrexed Spirig HC 100 mg
85.10
108.95
10 %
Concentrate for infusion: Pemetrexedum 100mg / 4ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Pemetrexed Spirig HC 500 mg
425.50
479.15
10 %
Concentrate for infusion: Pemetrexedum 500mg / 20ml
Spirig HealthCare AG
A / SL / SG
FB
G
L
IP
Pemetrexed Spirig HC 1000 mg
851.00
941.95
10 %
Concentrate for infusion: Pemetrexedum 1000mg / 40ml
Spirig HealthCare AG
● 
A / SL / SG
FB
G
L
IP
CI
Deferasirox NOBEL 90 mg
30
143.41
172.40
10 %
Coated tablets: Deferasiroxum 90 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox NOBEL 90 mg
90
365.68
414.10
10 %
Coated tablets: Deferasiroxum 90 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Deferasirox NOBEL 180 mg
30
235.19
272.20
10 %
Coated tablets: Deferasiroxum 180 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Deferasirox NOBEL 180 mg
90
599.72
668.65
10 %
Coated tablets: Deferasiroxum 180 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Deferasirox NOBEL 360 mg
30
385.70
435.90
10 %
Coated tablets: Deferasiroxum 360 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
Deferasirox NOBEL 360 mg
90
983.53
1086.05
10 %
Coated tablets: Deferasiroxum 360 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox-Mepha 90 mg
30
143.41
172.40
10 %
Coated tablets: Deferasiroxum 90 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox-Mepha 90 mg
90
365.68
414.10
10 %
Coated tablets: Deferasiroxum 90 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 180 mg
30
235.19
272.20
10 %
Coated tablets: Deferasiroxum 180 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 180 mg
90
599.72
668.65
10 %
Coated tablets: Deferasiroxum 180 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 360 mg
30
385.70
435.90
10 %
Coated tablets: Deferasiroxum 360 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 360 mg
90
983.53
1086.05
10 %
Coated tablets: Deferasiroxum 360 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan-Amlodipin-HCT-
Mepha 20 mg/5 mg/12,5 mg
28
15.93
33.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan-Amlodipin-HCT-
Mepha 20 mg/5 mg/12,5 mg
98
45.47
65.90
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/12,5 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/12,5 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/12,5 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/12,5 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/25 mg
28
19.69
37.85
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/5 mg/25 mg
98
56.67
78.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/25 mg
28
20.53
38.75
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Olmesartan-Amlodipin-HCT-
Mepha 40 mg/10 mg/25 mg
98
62.18
84.05
10 %
Coated tablets: 3 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Venlafaxin Spirig HC
retard 37.5 mg
10
2.70
12.15
10 %
Capsules: Venlafaxinum 37.5 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Venlafaxin Spirig HC
retard 37.5 mg
30
7.52
17.40
10 %
Capsules: Venlafaxinum 37.5 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 75 mg
14
5.66
15.45
10 %
Capsules: Venlafaxinum 75 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 75 mg
28
12.03
29.50
10 %
Capsules: Venlafaxinum 75 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 75 mg
98
44.12
64.35
10 %
Capsules: Venlafaxinum 75 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 150 mg
14
11.00
28.40
10 %
Capsules: Venlafaxinum 150 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 150 mg
28
21.75
40.10
10 %
Capsules: Venlafaxinum 150 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 150 mg
98
77.67
100.80
10 %
Capsules: Venlafaxinum 150 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 225 mg
28
27.58
46.40
10 %
Capsules: Venlafaxinum 225 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Venlafaxin Spirig HC
retard 225 mg
98
96.53
121.40
10 %
Capsules: Venlafaxinum 225 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Posaconazol Devatis
40mg/ml
105 ml
513.14
574.50
10 %
Suspension (oral): Posaconazolum 200mg / 5ml
Devatis AG
B / SL / SG
FB
G
IP
Risperidon-Mepha LA 25 mg
72.22
94.95
10 %
Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. Injektion: Risperidonum 25 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
Risperidon-Mepha LA 37.5 mg
100.21
125.40
10 %
Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. Injektion: Risperidonum 37.5 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
Risperidon-Mepha LA 50 mg
122.75
149.90
10 %
Pulver und Lösungsmittel zur Herstellung einer Suspension zur i.m. Injektion: Risperidonum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bexin Efeu Hustensirup
100 ml
4.46
8.25
10 %
Spirig HealthCare AG
D / SL
FB
G
L
IP
DARZALEX SC 1800 mg/15 ml
4788.48
5220.80
10 %
Injection solution: Daratumumabum 1800mg / 15ml
Janssen-Cilag AG
A / SL
FB
G
L
IP
Trecondi 1 g
114.23
140.65
10 %
Lyophilisate: Treosulfanum 1 g
Ideogen AG
A / SL
FB
G
L
IP
Trecondi 5 g
548.76
613.25
10 %
Lyophilisate: Treosulfanum 5 g
Ideogen AG
A / SL
FB
G
L
IP
CI
Zeposia 0.23 mg
293.96
336.10
10 %
Capsules: Ozanimodum
Bristol-Myers Squibb SA
B / SL
FB
G
L
IP
Zeposia 0.92 mg
28
1175.82
1295.20
10 %
Capsules: Ozanimodum
Bristol-Myers Squibb SA
B / SL
FB
G
IP
CI
Mictonorm 30 mg
28
22.93
41.35
10 %
Gélules à libération modifiée: Propiverini Hydrochloridum 30 mg
Labatec Pharma SA
B / SL
FB
G
IP
CI
Mictonorm 30 mg
84
58.47
80.00
10 %
Gélules à libération modifiée: Propiverini Hydrochloridum 30 mg
Labatec Pharma SA
B / SL
FB
G
L
IP
CI
Pelgraz 6 mg/0.6 ml
1001.72
1105.85
10 %
Injektionslösung in Fertiginjektor: Pegfilgrastimum 6mg / 0.6ml
Accord Healthcare AG
A / SL
FB
G
IP
Prilocain Hyperbar
Sintetica 20 mg/ml
10 x 5 ml
PR
PR
k.A.
Injection solution: Prilocaini Hydrochloridum 20 mg/ml
Sintetica SA
B
FB
G
IP
Prilocain Hyperbar
Sintetica 20 mg/ml
10 x 5 ml
PR
PR
k.A.
Injection solution: Prilocaini Hydrochloridum 20 mg/ml
Sintetica SA
B
FB
G
IP
Fulvestrant Accord 250
mg/5 ml
PR
PR
k.A.
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Accord Healthcare AG
B
FB
G
IP
Zeposia 0.46 mg
PR
PR
k.A.
Capsules: Ozanimodum
Bristol-Myers Squibb SA
B
FB
G
IP
CI
Mictonorm 30 mg
7
PR
PR
k.A.
Gélules à libération modifiée: Propiverini Hydrochloridum 30 mg
Labatec Pharma SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home